retatrutide mechanism triple agonist gip glp-1 glucagon retatrutide Science Behind GLP 1 GIP and Glucagon Receptor Substack Series 3 of 6:
Description
Discontinuation rates due to adverse events were 4.1% (4 mg), 6.9% (9 mg), and 11.3% (12 mg), compared with 4.9% for placebo
Provide complete information about your Wegovy treatment, dosage, any side effects, and underlying health conditions so clinical staff can assess your eligibility according to current NHSBT guidelines
And you know the ceiling: 15 mg is the maximum
Follow her on X @VeronicaHPaulus
What retatrutide does for blood sugar and diabetes Retatrutide is being trialled as a treatment for type 2 diabetes as well as obesity
